BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11817266)

  • 1. Retrospective study of topiramate in a paediatric population with intractable epilepsy showing promising effects in the West syndrome patients.
    Thijs J; Verhelst H; Van Coster R
    Acta Neurol Belg; 2001 Sep; 101(3):171-6. PubMed ID: 11817266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate for drug-resistant epilepsies.
    Yeung S; Ferrie CD; Murdoch-Eaton DG; Livingston JH
    Eur J Paediatr Neurol; 2000; 4(1):31-3. PubMed ID: 10701102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: with special reference to electroencephalographic changes.
    Endoh F; Kobayashi K; Hayashi Y; Shibata T; Yoshinaga H; Ohtsuka Y
    Seizure; 2012 Sep; 21(7):522-8. PubMed ID: 22698380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobazam as add-on therapy in children with epileptic encephalopathy.
    Silva RC; Montenegro MA; Guerreiro CA; Guerreiro MM
    Can J Neurol Sci; 2006 May; 33(2):209-13. PubMed ID: 16736732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in the treatment of severe myoclonic epilepsy in infancy.
    Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR
    Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of adjunctive therapy with zonisamide in childhood intractable epilepsy.
    Lee YJ; Kang HC; Seo JH; Lee JS; Kim HD
    Brain Dev; 2010 Mar; 32(3):208-12. PubMed ID: 19304420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate in the treatment of highly refractory patients with Dravet syndrome.
    Kröll-Seger J; Portilla P; Dulac O; Chiron C
    Neuropediatrics; 2006 Dec; 37(6):325-9. PubMed ID: 17357033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes.
    Haberlandt E; Weger C; Sigl SB; Rauchenzauner M; Scholl-Bürgi S; Rostásy K; Karall D
    Pediatr Neurol; 2010 Jan; 42(1):21-7. PubMed ID: 20004858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients.
    Korinthenberg R; Schreiner A
    J Child Neurol; 2007 Mar; 22(3):302-6. PubMed ID: 17621500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of topiramate in infants according to epilepsy syndromes.
    Grosso S; Galimberti D; Farnetani MA; Cioni M; Mostardini R; Vivarelli R; Di Bartolo RM; Bernardoni E; Berardi R; Morgese G; Balestri P
    Seizure; 2005 Apr; 14(3):183-9. PubMed ID: 15797353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. West syndrome, can topiramate be on top?
    Al-Baradie RS; Elseed MA
    Neurosciences (Riyadh); 2011 Jan; 16(1):53-6. PubMed ID: 21206445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH.
    Zhu X; Chen O; Zhang D; Jin R; Li F; Wang Y; Sun R
    Epilepsy Res; 2011 Feb; 93(2-3):149-54. PubMed ID: 21205578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study.
    Baker GA; Currie NG; Light MJ; Schneiderman JH;
    Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of topiramate on intractable seizures in Taiwanese children.
    Li ST; Shen EY; Chiu NC; Ho CS
    Acta Neurol Taiwan; 2004 Jun; 13(2):59-63. PubMed ID: 15478676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms.
    Zou LP; Lin Q; Qin J; Cai FC; Liu ZS; Mix E;
    Clin Neuropharmacol; 2008; 31(2):86-92. PubMed ID: 18382180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in childhood epileptic encephalopathy with continuous spike-waves during sleep: A retrospective study of 21 cases.
    Vrielynck P; Marique P; Ghariani S; Lienard F; de Borchgrave V; van Rijckevorsel K; Bonnier C
    Eur J Paediatr Neurol; 2017 Mar; 21(2):305-311. PubMed ID: 27641809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of topiramate in the treatment of infantile spasms.
    Glauser TA; Clark PO; Strawsburg R
    Epilepsia; 1998 Dec; 39(12):1324-8. PubMed ID: 9860068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.